Selective Benefit of Low Dose Methotrexate on Positive Symptoms of Schizophrenia in a Randomized Double-Blind Placebo-Controlled 12-Week Feasibility Trial
NEUROPSYCHOPHARMACOLOGY（2016）
关键词
Schizophrenia,Methotrexate,Clinical Trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要